Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: A population-based cohort study

Clinical Infectious Diseases

Volumn 58, Issue 2, 2014, Pages 197-203

  Kuo, Shu Chen ^a,b   Chen, Yung Tai ^a,c,d   Lee, Yi Tzu ^a,e   Fan, Nai Wen ^f   Chen, Shih Jen ^f   Li, Szu Yuan ^a,c   Liu, Chia Jen ^a,c   Chen, Te Li ^a   Chen, Tzeng Ji ^c   Fung, Chang Phone ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e Emergency Department   (Taiwan)

^f Emergency Department ^*  (Taiwan)

Author keywords

Fluoroquinolones; Rhegmatogenous retinal detachment; Risks

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; NORFLOXACIN; OFLOXACIN;

ADULT; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; DEMENTIA; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; OBSERVATIONAL STUDY; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETINA DETACHMENT; RETROSPECTIVE STUDY; RISK;

FLUOROQUINOLONES; RHEGMATOGENOUS RETINAL DETACHMENT; RISKS;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84891792341     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit708     Document Type: Article

References (27)

1. Sorgel F, Jaehde U, Naber K, Stephan U. Pharmacokinetic disposition of quinolones in human body fluids and tissues. Clin Pharmacokinet 1989; 16(suppl 1):5-24
2. Owens RC Jr, Ambrose PG. Antimicrobial safety: Focus on fluoroquinolones. Clin Infect Dis 2005; 41(suppl 2):S144-57
3. Etminan M, Forooghian F, Brophy JM, Bird ST, Maberley D. Oral fluoroquinolones and the risk of retinal detachment. JAMA 2012; 307: 1414-9
4. Han DP, Szabo A. Flashes, floaters, and oral fluoroquinolones. Arch Ophthalmol 2012; 131:1-3
5. Smith A, Pennefather PM, Kaye SB, Hart CA. Fluoroquinolones: Place in ocular therapy. Drugs 2001; 61:747-61
6. Rao RC, Dlouhy BJ. Retinal detachment and fluoroquinolones. JAMA 2012; 308:233-4
7. Molloy AC, Mitry D. Retinal detachment and fluoroquinolones. JAMA 2012; 308:234-5
8. Aristodemou P, Stylianides AC. Retinal detachment and fluoroquinolones. JAMA 2012; 308:234
9. Nowroozzadeh MH. Retinal detachment and fluoroquinolones. JAMA 2012; 308:233
10. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45:613-9
11. Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012; 366:1881-90
12. Freeman WR, Friedberg DN, Berry C, et al. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 1993; 116:713-20
13. Tuft SJ, Minassian D, Sullivan P. Risk factors for retinal detachment after cataract surgery: A case-control study. Ophthalmology 2006; 113:650-6
14. The Eye Disease Case-Control Study Group. Risk factors for idiopathic rhegmatogenous retinal detachment. Am J Epidemiol 1993; 137:749-57
15. Haimann MH, Burton TC, Brown CK. Epidemiology of retinal detachment. Arch Ophthalmol 1982; 100:289-92
16. Witmer MT, Cohen SM. Oral anticoagulation and the risk of vitreous hemorrhage and retinal tears in eyes with acute posterior vitreous detachment. Retina 2012; 33:621-6
17. Algvere P. Retinal detachment and pathology following experimental embolization of choroidal and retinal circulation. Albrecht von Graefes Arch Klin Exp Ophthalmol 1976; 201:123-34
18. Stahlmann R, Lode H. Toxicity of quinolones. Drugs 1999; 58(suppl 2): 37-42
19. Khaliq Y, Zhanel GG. Fluoroquinolone-Associated tendinopathy: A critical review of the literature. Clin Infect Dis 2003; 36:1404-10
20. El Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG, Liggett PE. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992; 99:483-6
21. Domagala JM. Structure-Activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994; 33:685-706
22. Cekic O, Batman C, Yasar U, Basci NE, Zilelioglu O, Bozkurt A. Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans. Br J Ophthalmol 2000; 84:1061-3
23. George JM, Fiscella R, Blair M, et al. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration. J Ocul Pharmacol Ther 2010; 26:579-86
24. Sakamoto H, Sakamoto M, Hata Y, Kubota T, Ishibashi T. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration. Eur J Ophthalmol 2007; 17:372-6
25. Fiscella RG, Nguyen TK, Cwik MJ, et al. Aqueous and vitreous penetration of levofloxacin after oral administration. Ophthalmology 1999; 106:2286-90
26. Cekic O, Batman C, Yasar U, Basci NE, Bozkurt A, Kayaalp SO. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration. Retina 1998; 18:521-5
27. Akahane K, Sekiguchi M, Une T, Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-Aminobutyric acid receptor sites. Antimicrob Agents Chemother 1989; 33:1704-8